GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes
Marx N, Husain M, Lehrke M, et al.
Circulation. 2022;146:1882-1894.
Leggi
Marx N, Husain M, Lehrke M, et al.
Circulation. 2022;146:1882-1894.
Leggi
Malone JI, Gao X, Lorenzi GM, et al.
Diabetes Care. dc221711.
Leggi
Salam M, Bailey R, Calhoun P, et al.
Diabetes Technol Ther. Pub. online 6 Dec 2022.
Leggi
Garg SK, Grunberger G, Weinstock RS, et al.
Diabetes Technol Ther. Pub. online 6 Dec 2022.
Leggi
Trott M, Driscoll R, Pardhan S
BMC Endocr Disord. 2022;22(1):311.
Leggi
Pathak S, Kearin K, Kahkoska A et al.
Diabetes Technol Ther. Pub. online 8 Dec 2022.
Leggi
Battelino T, Alexander CM, Amiel SA, et al.
The Lancet Diabetes and Endocrinology. Pub. online, 6 December 2022.
Leggi
Maalmi H, Strom A, Petrera A, et al.
Diabetologia. Pub. online 6 Dec 2022.
Leggi
Cheung JTK, Yang A, Wu H, et al.
Diabetes Res Clin Pract. Pub. online 6 Dec 2022.
Leggi
Golovaty I, Ritchie ND, Tuomilehto J, et al.
Diabetes Res Clin Pract. 2022;110195.
Leggi